Loading…
Reversible silencing of cytomegalovirus genomes by type I interferon governs virus latency
Herpesviruses establish a lifelong latent infection posing the risk for virus reactivation and disease. In cytomegalovirus infection, expression of the major immediate early (IE) genes is a critical checkpoint, driving the lytic replication cycle upon primary infection or reactivation from latency....
Saved in:
Published in: | PLoS pathogens 2014-02, Vol.10 (2), p.e1003962-e1003962 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c526t-ecc5ba461e27ba3235b7eb4a050dd4e202d8b9362710dc35a1409f4fc8b8856c3 |
---|---|
cites | cdi_FETCH-LOGICAL-c526t-ecc5ba461e27ba3235b7eb4a050dd4e202d8b9362710dc35a1409f4fc8b8856c3 |
container_end_page | e1003962 |
container_issue | 2 |
container_start_page | e1003962 |
container_title | PLoS pathogens |
container_volume | 10 |
creator | Dağ, Franziska Dölken, Lars Holzki, Julia Drabig, Anja Weingärtner, Adrien Schwerk, Johannes Lienenklaus, Stefan Conte, Ianina Geffers, Robert Davenport, Colin Rand, Ulfert Köster, Mario Weiß, Siegfried Adler, Barbara Wirth, Dagmar Messerle, Martin Hauser, Hansjörg Cičin-Šain, Luka |
description | Herpesviruses establish a lifelong latent infection posing the risk for virus reactivation and disease. In cytomegalovirus infection, expression of the major immediate early (IE) genes is a critical checkpoint, driving the lytic replication cycle upon primary infection or reactivation from latency. While it is known that type I interferon (IFN) limits lytic CMV replication, its role in latency and reactivation has not been explored. In the model of mouse CMV infection, we show here that IFNβ blocks mouse CMV replication at the level of IE transcription in IFN-responding endothelial cells and fibroblasts. The IFN-mediated inhibition of IE genes was entirely reversible, arguing that the IFN-effect may be consistent with viral latency. Importantly, the response to IFNβ is stochastic, and MCMV IE transcription and replication were repressed only in IFN-responsive cells, while the IFN-unresponsive cells remained permissive for lytic MCMV infection. IFN blocked the viral lytic replication cycle by upregulating the nuclear domain 10 (ND10) components, PML, Sp100 and Daxx, and their knockdown by shRNA rescued viral replication in the presence of IFNβ. Finally, IFNβ prevented MCMV reactivation from endothelial cells derived from latently infected mice, validating our results in a biologically relevant setting. Therefore, our data do not only define for the first time the molecular mechanism of IFN-mediated control of CMV infection, but also indicate that the reversible inhibition of the virus lytic cycle by IFNβ is consistent with the establishment of CMV latency. |
doi_str_mv | 10.1371/journal.ppat.1003962 |
format | article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_gale_infotracmisc_A364854203</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A364854203</galeid><doaj_id>oai_doaj_org_article_095f735c42a44447901e4efb355df8b6</doaj_id><sourcerecordid>A364854203</sourcerecordid><originalsourceid>FETCH-LOGICAL-c526t-ecc5ba461e27ba3235b7eb4a050dd4e202d8b9362710dc35a1409f4fc8b8856c3</originalsourceid><addsrcrecordid>eNpVkluL1DAUgIso7kX_gWjBF19mzL3ti7Asug4sCKIvvoQkPakZMsmYtAv992a23WU3L7l950tycqrqHUZbTBv8eR-nFJTfHo9q3GKEaCfIi-occ043DW3Yyyfjs-oi5z1CDFMsXldnhPFWYMHPqz8_4Q5SdtpDnZ2HYFwY6mhrM4_xAIPy8c6lKdcDhDLPtZ7rcT5CvatdGCFZSDHUQyySkOsF9WosnvlN9coqn-Ht2l9Wv799_XX9fXP742Z3fXW7MZyIcQPGcK2YwEAarSihXDegmUIc9T0Dgkjf6o4K0mDUG8oVZqizzJpWty0Xhl5WHxbv0ccs17RkiTlqWkpE1xZitxB9VHt5TO6g0iyjcvJ-IaZBqjQ640GijtuGcsOIYqU1HcLAwGrKeW9bLYrry3rapA_QGwhjUv6Z9PlOcH9lyY-kHUW87Yrg0ypI8d8EeZQHlw14rwLE6f7eDAskCC7oxwUt3wDSBRuL0ZxweUUFazkjiBaKLZRJMecE9vEyGMlTqTzkRJ5KRa6lUsLeP33IY9BDbdD_p9y9pQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1504160621</pqid></control><display><type>article</type><title>Reversible silencing of cytomegalovirus genomes by type I interferon governs virus latency</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Dağ, Franziska ; Dölken, Lars ; Holzki, Julia ; Drabig, Anja ; Weingärtner, Adrien ; Schwerk, Johannes ; Lienenklaus, Stefan ; Conte, Ianina ; Geffers, Robert ; Davenport, Colin ; Rand, Ulfert ; Köster, Mario ; Weiß, Siegfried ; Adler, Barbara ; Wirth, Dagmar ; Messerle, Martin ; Hauser, Hansjörg ; Cičin-Šain, Luka</creator><creatorcontrib>Dağ, Franziska ; Dölken, Lars ; Holzki, Julia ; Drabig, Anja ; Weingärtner, Adrien ; Schwerk, Johannes ; Lienenklaus, Stefan ; Conte, Ianina ; Geffers, Robert ; Davenport, Colin ; Rand, Ulfert ; Köster, Mario ; Weiß, Siegfried ; Adler, Barbara ; Wirth, Dagmar ; Messerle, Martin ; Hauser, Hansjörg ; Cičin-Šain, Luka</creatorcontrib><description>Herpesviruses establish a lifelong latent infection posing the risk for virus reactivation and disease. In cytomegalovirus infection, expression of the major immediate early (IE) genes is a critical checkpoint, driving the lytic replication cycle upon primary infection or reactivation from latency. While it is known that type I interferon (IFN) limits lytic CMV replication, its role in latency and reactivation has not been explored. In the model of mouse CMV infection, we show here that IFNβ blocks mouse CMV replication at the level of IE transcription in IFN-responding endothelial cells and fibroblasts. The IFN-mediated inhibition of IE genes was entirely reversible, arguing that the IFN-effect may be consistent with viral latency. Importantly, the response to IFNβ is stochastic, and MCMV IE transcription and replication were repressed only in IFN-responsive cells, while the IFN-unresponsive cells remained permissive for lytic MCMV infection. IFN blocked the viral lytic replication cycle by upregulating the nuclear domain 10 (ND10) components, PML, Sp100 and Daxx, and their knockdown by shRNA rescued viral replication in the presence of IFNβ. Finally, IFNβ prevented MCMV reactivation from endothelial cells derived from latently infected mice, validating our results in a biologically relevant setting. Therefore, our data do not only define for the first time the molecular mechanism of IFN-mediated control of CMV infection, but also indicate that the reversible inhibition of the virus lytic cycle by IFNβ is consistent with the establishment of CMV latency.</description><identifier>ISSN: 1553-7374</identifier><identifier>ISSN: 1553-7366</identifier><identifier>EISSN: 1553-7374</identifier><identifier>DOI: 10.1371/journal.ppat.1003962</identifier><identifier>PMID: 24586165</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Animals ; Biology ; Cell Separation ; Cytomegalovirus ; Cytomegalovirus - genetics ; Cytomegalovirus Infections - genetics ; Cytomegalovirus Infections - immunology ; Cytomegaloviruses ; Disease Models, Animal ; Fluorescent Antibody Technique ; Gene Expression Regulation, Viral - genetics ; Gene Silencing ; Genes ; Genes, Immediate-Early - genetics ; Genetic aspects ; Genetic research ; Genome, Viral ; Genomes ; High-Throughput Nucleotide Sequencing ; Immune system ; Interferon ; Interferon Type I - genetics ; Medicine ; Mice ; Microbiological research ; Mortality ; Plasmids ; Reverse Transcriptase Polymerase Chain Reaction ; Virus Latency - genetics ; Virus Replication - genetics</subject><ispartof>PLoS pathogens, 2014-02, Vol.10 (2), p.e1003962-e1003962</ispartof><rights>COPYRIGHT 2014 Public Library of Science</rights><rights>2014 Dag et al 2014 Dag et al</rights><rights>2014 Dag et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Da? F, Dölken L, Holzki J, Drabig A, Weingärtner A, et al. (2014) Reversible Silencing of Cytomegalovirus Genomes by Type I Interferon Governs Virus Latency. PLoS Pathog 10(2): e1003962. doi:10.1371/journal.ppat.1003962</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c526t-ecc5ba461e27ba3235b7eb4a050dd4e202d8b9362710dc35a1409f4fc8b8856c3</citedby><cites>FETCH-LOGICAL-c526t-ecc5ba461e27ba3235b7eb4a050dd4e202d8b9362710dc35a1409f4fc8b8856c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930589/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930589/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,36990,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24586165$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dağ, Franziska</creatorcontrib><creatorcontrib>Dölken, Lars</creatorcontrib><creatorcontrib>Holzki, Julia</creatorcontrib><creatorcontrib>Drabig, Anja</creatorcontrib><creatorcontrib>Weingärtner, Adrien</creatorcontrib><creatorcontrib>Schwerk, Johannes</creatorcontrib><creatorcontrib>Lienenklaus, Stefan</creatorcontrib><creatorcontrib>Conte, Ianina</creatorcontrib><creatorcontrib>Geffers, Robert</creatorcontrib><creatorcontrib>Davenport, Colin</creatorcontrib><creatorcontrib>Rand, Ulfert</creatorcontrib><creatorcontrib>Köster, Mario</creatorcontrib><creatorcontrib>Weiß, Siegfried</creatorcontrib><creatorcontrib>Adler, Barbara</creatorcontrib><creatorcontrib>Wirth, Dagmar</creatorcontrib><creatorcontrib>Messerle, Martin</creatorcontrib><creatorcontrib>Hauser, Hansjörg</creatorcontrib><creatorcontrib>Cičin-Šain, Luka</creatorcontrib><title>Reversible silencing of cytomegalovirus genomes by type I interferon governs virus latency</title><title>PLoS pathogens</title><addtitle>PLoS Pathog</addtitle><description>Herpesviruses establish a lifelong latent infection posing the risk for virus reactivation and disease. In cytomegalovirus infection, expression of the major immediate early (IE) genes is a critical checkpoint, driving the lytic replication cycle upon primary infection or reactivation from latency. While it is known that type I interferon (IFN) limits lytic CMV replication, its role in latency and reactivation has not been explored. In the model of mouse CMV infection, we show here that IFNβ blocks mouse CMV replication at the level of IE transcription in IFN-responding endothelial cells and fibroblasts. The IFN-mediated inhibition of IE genes was entirely reversible, arguing that the IFN-effect may be consistent with viral latency. Importantly, the response to IFNβ is stochastic, and MCMV IE transcription and replication were repressed only in IFN-responsive cells, while the IFN-unresponsive cells remained permissive for lytic MCMV infection. IFN blocked the viral lytic replication cycle by upregulating the nuclear domain 10 (ND10) components, PML, Sp100 and Daxx, and their knockdown by shRNA rescued viral replication in the presence of IFNβ. Finally, IFNβ prevented MCMV reactivation from endothelial cells derived from latently infected mice, validating our results in a biologically relevant setting. Therefore, our data do not only define for the first time the molecular mechanism of IFN-mediated control of CMV infection, but also indicate that the reversible inhibition of the virus lytic cycle by IFNβ is consistent with the establishment of CMV latency.</description><subject>Animals</subject><subject>Biology</subject><subject>Cell Separation</subject><subject>Cytomegalovirus</subject><subject>Cytomegalovirus - genetics</subject><subject>Cytomegalovirus Infections - genetics</subject><subject>Cytomegalovirus Infections - immunology</subject><subject>Cytomegaloviruses</subject><subject>Disease Models, Animal</subject><subject>Fluorescent Antibody Technique</subject><subject>Gene Expression Regulation, Viral - genetics</subject><subject>Gene Silencing</subject><subject>Genes</subject><subject>Genes, Immediate-Early - genetics</subject><subject>Genetic aspects</subject><subject>Genetic research</subject><subject>Genome, Viral</subject><subject>Genomes</subject><subject>High-Throughput Nucleotide Sequencing</subject><subject>Immune system</subject><subject>Interferon</subject><subject>Interferon Type I - genetics</subject><subject>Medicine</subject><subject>Mice</subject><subject>Microbiological research</subject><subject>Mortality</subject><subject>Plasmids</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Virus Latency - genetics</subject><subject>Virus Replication - genetics</subject><issn>1553-7374</issn><issn>1553-7366</issn><issn>1553-7374</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkluL1DAUgIso7kX_gWjBF19mzL3ti7Asug4sCKIvvoQkPakZMsmYtAv992a23WU3L7l950tycqrqHUZbTBv8eR-nFJTfHo9q3GKEaCfIi-occ043DW3Yyyfjs-oi5z1CDFMsXldnhPFWYMHPqz8_4Q5SdtpDnZ2HYFwY6mhrM4_xAIPy8c6lKdcDhDLPtZ7rcT5CvatdGCFZSDHUQyySkOsF9WosnvlN9coqn-Ht2l9Wv799_XX9fXP742Z3fXW7MZyIcQPGcK2YwEAarSihXDegmUIc9T0Dgkjf6o4K0mDUG8oVZqizzJpWty0Xhl5WHxbv0ccs17RkiTlqWkpE1xZitxB9VHt5TO6g0iyjcvJ-IaZBqjQ640GijtuGcsOIYqU1HcLAwGrKeW9bLYrry3rapA_QGwhjUv6Z9PlOcH9lyY-kHUW87Yrg0ypI8d8EeZQHlw14rwLE6f7eDAskCC7oxwUt3wDSBRuL0ZxweUUFazkjiBaKLZRJMecE9vEyGMlTqTzkRJ5KRa6lUsLeP33IY9BDbdD_p9y9pQ</recordid><startdate>20140201</startdate><enddate>20140201</enddate><creator>Dağ, Franziska</creator><creator>Dölken, Lars</creator><creator>Holzki, Julia</creator><creator>Drabig, Anja</creator><creator>Weingärtner, Adrien</creator><creator>Schwerk, Johannes</creator><creator>Lienenklaus, Stefan</creator><creator>Conte, Ianina</creator><creator>Geffers, Robert</creator><creator>Davenport, Colin</creator><creator>Rand, Ulfert</creator><creator>Köster, Mario</creator><creator>Weiß, Siegfried</creator><creator>Adler, Barbara</creator><creator>Wirth, Dagmar</creator><creator>Messerle, Martin</creator><creator>Hauser, Hansjörg</creator><creator>Cičin-Šain, Luka</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20140201</creationdate><title>Reversible silencing of cytomegalovirus genomes by type I interferon governs virus latency</title><author>Dağ, Franziska ; Dölken, Lars ; Holzki, Julia ; Drabig, Anja ; Weingärtner, Adrien ; Schwerk, Johannes ; Lienenklaus, Stefan ; Conte, Ianina ; Geffers, Robert ; Davenport, Colin ; Rand, Ulfert ; Köster, Mario ; Weiß, Siegfried ; Adler, Barbara ; Wirth, Dagmar ; Messerle, Martin ; Hauser, Hansjörg ; Cičin-Šain, Luka</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c526t-ecc5ba461e27ba3235b7eb4a050dd4e202d8b9362710dc35a1409f4fc8b8856c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Biology</topic><topic>Cell Separation</topic><topic>Cytomegalovirus</topic><topic>Cytomegalovirus - genetics</topic><topic>Cytomegalovirus Infections - genetics</topic><topic>Cytomegalovirus Infections - immunology</topic><topic>Cytomegaloviruses</topic><topic>Disease Models, Animal</topic><topic>Fluorescent Antibody Technique</topic><topic>Gene Expression Regulation, Viral - genetics</topic><topic>Gene Silencing</topic><topic>Genes</topic><topic>Genes, Immediate-Early - genetics</topic><topic>Genetic aspects</topic><topic>Genetic research</topic><topic>Genome, Viral</topic><topic>Genomes</topic><topic>High-Throughput Nucleotide Sequencing</topic><topic>Immune system</topic><topic>Interferon</topic><topic>Interferon Type I - genetics</topic><topic>Medicine</topic><topic>Mice</topic><topic>Microbiological research</topic><topic>Mortality</topic><topic>Plasmids</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Virus Latency - genetics</topic><topic>Virus Replication - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dağ, Franziska</creatorcontrib><creatorcontrib>Dölken, Lars</creatorcontrib><creatorcontrib>Holzki, Julia</creatorcontrib><creatorcontrib>Drabig, Anja</creatorcontrib><creatorcontrib>Weingärtner, Adrien</creatorcontrib><creatorcontrib>Schwerk, Johannes</creatorcontrib><creatorcontrib>Lienenklaus, Stefan</creatorcontrib><creatorcontrib>Conte, Ianina</creatorcontrib><creatorcontrib>Geffers, Robert</creatorcontrib><creatorcontrib>Davenport, Colin</creatorcontrib><creatorcontrib>Rand, Ulfert</creatorcontrib><creatorcontrib>Köster, Mario</creatorcontrib><creatorcontrib>Weiß, Siegfried</creatorcontrib><creatorcontrib>Adler, Barbara</creatorcontrib><creatorcontrib>Wirth, Dagmar</creatorcontrib><creatorcontrib>Messerle, Martin</creatorcontrib><creatorcontrib>Hauser, Hansjörg</creatorcontrib><creatorcontrib>Cičin-Šain, Luka</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PLoS pathogens</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dağ, Franziska</au><au>Dölken, Lars</au><au>Holzki, Julia</au><au>Drabig, Anja</au><au>Weingärtner, Adrien</au><au>Schwerk, Johannes</au><au>Lienenklaus, Stefan</au><au>Conte, Ianina</au><au>Geffers, Robert</au><au>Davenport, Colin</au><au>Rand, Ulfert</au><au>Köster, Mario</au><au>Weiß, Siegfried</au><au>Adler, Barbara</au><au>Wirth, Dagmar</au><au>Messerle, Martin</au><au>Hauser, Hansjörg</au><au>Cičin-Šain, Luka</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reversible silencing of cytomegalovirus genomes by type I interferon governs virus latency</atitle><jtitle>PLoS pathogens</jtitle><addtitle>PLoS Pathog</addtitle><date>2014-02-01</date><risdate>2014</risdate><volume>10</volume><issue>2</issue><spage>e1003962</spage><epage>e1003962</epage><pages>e1003962-e1003962</pages><issn>1553-7374</issn><issn>1553-7366</issn><eissn>1553-7374</eissn><abstract>Herpesviruses establish a lifelong latent infection posing the risk for virus reactivation and disease. In cytomegalovirus infection, expression of the major immediate early (IE) genes is a critical checkpoint, driving the lytic replication cycle upon primary infection or reactivation from latency. While it is known that type I interferon (IFN) limits lytic CMV replication, its role in latency and reactivation has not been explored. In the model of mouse CMV infection, we show here that IFNβ blocks mouse CMV replication at the level of IE transcription in IFN-responding endothelial cells and fibroblasts. The IFN-mediated inhibition of IE genes was entirely reversible, arguing that the IFN-effect may be consistent with viral latency. Importantly, the response to IFNβ is stochastic, and MCMV IE transcription and replication were repressed only in IFN-responsive cells, while the IFN-unresponsive cells remained permissive for lytic MCMV infection. IFN blocked the viral lytic replication cycle by upregulating the nuclear domain 10 (ND10) components, PML, Sp100 and Daxx, and their knockdown by shRNA rescued viral replication in the presence of IFNβ. Finally, IFNβ prevented MCMV reactivation from endothelial cells derived from latently infected mice, validating our results in a biologically relevant setting. Therefore, our data do not only define for the first time the molecular mechanism of IFN-mediated control of CMV infection, but also indicate that the reversible inhibition of the virus lytic cycle by IFNβ is consistent with the establishment of CMV latency.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>24586165</pmid><doi>10.1371/journal.ppat.1003962</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1553-7374 |
ispartof | PLoS pathogens, 2014-02, Vol.10 (2), p.e1003962-e1003962 |
issn | 1553-7374 1553-7366 1553-7374 |
language | eng |
recordid | cdi_gale_infotracmisc_A364854203 |
source | Publicly Available Content Database; PubMed Central |
subjects | Animals Biology Cell Separation Cytomegalovirus Cytomegalovirus - genetics Cytomegalovirus Infections - genetics Cytomegalovirus Infections - immunology Cytomegaloviruses Disease Models, Animal Fluorescent Antibody Technique Gene Expression Regulation, Viral - genetics Gene Silencing Genes Genes, Immediate-Early - genetics Genetic aspects Genetic research Genome, Viral Genomes High-Throughput Nucleotide Sequencing Immune system Interferon Interferon Type I - genetics Medicine Mice Microbiological research Mortality Plasmids Reverse Transcriptase Polymerase Chain Reaction Virus Latency - genetics Virus Replication - genetics |
title | Reversible silencing of cytomegalovirus genomes by type I interferon governs virus latency |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-24T00%3A04%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reversible%20silencing%20of%20cytomegalovirus%20genomes%20by%20type%20I%20interferon%20governs%20virus%20latency&rft.jtitle=PLoS%20pathogens&rft.au=Da%C4%9F,%20Franziska&rft.date=2014-02-01&rft.volume=10&rft.issue=2&rft.spage=e1003962&rft.epage=e1003962&rft.pages=e1003962-e1003962&rft.issn=1553-7374&rft.eissn=1553-7374&rft_id=info:doi/10.1371/journal.ppat.1003962&rft_dat=%3Cgale_plos_%3EA364854203%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c526t-ecc5ba461e27ba3235b7eb4a050dd4e202d8b9362710dc35a1409f4fc8b8856c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1504160621&rft_id=info:pmid/24586165&rft_galeid=A364854203&rfr_iscdi=true |